| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 151, 1455-1467, Copyright © 1997 by American Society for Investigative Pathology
REGULAR ARTICLES |
KL Simpson, A Jones, S Norman and CH Holmes
Department of Clinical Medicine, University of Bristol, St. Michael's Hospital, United Kingdom.
The membrane-bound complement regulators decay-accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46), and CD59 are broadly expressed proteins that act together to protect host tissues from autologous complement. Comparison of expression profiles of these proteins between normal and pathological tissues could reveal a mechanism by which tumor cells evade complement-mediated killing. Expression of the regulators was therefore examined in the normal human uterine cervix, in cervical intraepithelial neoplasia (CIN; n = 23), and in cervical squamous carcinomas (n = 6). DAF and MCP were reciprocally expressed in normal ectocervical epithelium. MCP was confined predominantly to the basal and parabasal layers with more extensive expression in metaplastic squamous epithelium. An apparent expansion in MCP expression was observed in more severe premalignant lesions whereas cervical carcinoma were uniformly MCP positive. By contrast, DAF expression appeared unaltered in premalignant lesions and variable in carcinomas. However, increased DAF was observed in stromal cells directly adjacent to infiltrating tumor cells. A low molecular weight DAF product was detected in tumors, and preliminary evidence suggests this may be derived from stromal cells. Overall, changes in expression of C3 convertase regulators in both the stromal and epithelial compartments may be important for evasion of immune surveillance in cervical cancer.
This article has been cited by other articles:
 |
|
 |
|
  M. S. Czuczman, S. Olejniczak, A. Gowda, A. Kotowski, A. Binder, H. Kaur, J. Knight, P. Starostik, J. Deans, and F. J. Hernandez-Ilizaliturri Acquirement of Rituximab Resistance in Lymphoma Cell Lines Is Associated with Both Global CD20 Gene and Protein Down-Regulation Regulated at the Pretranscriptional and Posttranscriptional Levels Clin. Cancer Res., March 1, 2008; 14(5): 1561 - 1570. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. V. Rozanov, A. Y. Savinov, V. S. Golubkov, S. Tomlinson, and A. Y. Strongin Interference with the complement system by tumor cell membrane type-1 matrix metalloproteinase plays a significant role in promoting metastasis in mice. Cancer Res., June 15, 2006; 66(12): 6258 - 6263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J. Hernandez-Ilizaliturri, V. Jupudy, J. Ostberg, E. Oflazoglu, A. Huberman, E. Repasky, and M. S. Czuczman Neutrophils Contribute to the Biological Antitumor Activity of Rituximab in a Non-Hodgkin's Lymphoma Severe Combined Immunodeficiency Mouse Model Clin. Cancer Res., December 1, 2003; 9(16): 5866 - 5873. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Inoue, M Yamakawa, and T Takahashi Expression of complement regulating factors in gastric cancer cells Mol. Pathol., June 1, 2002; 55(3): 193 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. G. Brodbeck, C. Mold, J. P. Atkinson, and M. E. Medof Cooperation Between Decay-Accelerating Factor and Membrane Cofactor Protein in Protecting Cells from Autologous Complement Attack J. Immunol., October 1, 2000; 165(7): 3999 - 4006. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Corey, R. J. Kinders, C. M. Poduje, C. L. Bruce, H. Rowley, L. G. Brown, G. M. Hass, and R. L. Vessella Mechanistic Studies of the Effects of Anti-factor H Antibodies on Complement-mediated Lysis J. Biol. Chem., April 21, 2000; 275(17): 12917 - 12925. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. S. Fedarko, B. Fohr, P. G. Robey, M. F. Young, and L. W. Fisher Factor H Binding to Bone Sialoprotein and Osteopontin Enables Tumor Cell Evasion of Complement-mediated Attack J. Biol. Chem., May 26, 2000; 275(22): 16666 - 16672. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
